ReviewAntibiotics (Basel, Switzerland)2021
Outcomes and Future Prospect of Japan's National Action Plan on Antimicrobial Resistance (2016-2020).
Review in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 37 citations in OpenAlex.
- Long-term National Trends in Pediatric Oral Antibiotic Prescriptions in Japan, 2011-2022.JMA journal · 2026Article
- Prevalence and economic evaluation of acute uncomplicated cystitis in women from Japan: a retrospective cohort study.JAC-antimicrobial resistance · 2025Article
- Revolutionizing pig farming: Japan's technological innovations and environmental strategies for sustainability.Journal of advanced veterinary and animal research · 2025Article
- Identifying factors improving the intention to use antibiotics appropriately in children and adults using protection motivation theory.PEC innovation · 2024Article
- Integrated surveillance systems for antibiotic resistance in a One Health context: a scoping review.BMC public health · 2024Article
- Incidence and mortality of community-acquired and nosocomial infections in Japan: a nationwide medical claims database study.BMC infectious diseases · 2024Article
- The effect of infectious diseases on lung transplantation in Japan.Journal of thoracic disease · 2024Review
- Surveillance of Antimicrobial Prescriptions in Community Pharmacies Located in Tokyo, Japan.Antibiotics (Basel, Switzerland) · 2023Article
- Antimicrobial resistance in food-producing animals: towards implementing a one health based national action plan in Israel.Israel journal of health policy research · 2023Review
- Investigation of oral macrolide prescriptions in Japan using a retrospective claims database, 2013-2018.PloS one · 2023Review
- Evaluation of Knowledge Regarding the Use of Antibiotics among Pharmacy Undergraduates in Japan.Journal of microbiology & biology education · 2022Article
- Evaluation of the Correspondence between the Concentration of Antimicrobials Entering Sewage Treatment Plant Influent and the Predicted Concentration of Antimicrobials Using Annual Sales, Shipping, and Prescriptions Data.Antibiotics (Basel, Switzerland) · 2022Article
- Infiltration of hidden antimicrobial resistance among healthy people in a Japanese community.JAC-antimicrobial resistance · 2022Article
- Clinical Implication of the Relationship between Antimicrobial Resistance and Infection Control Activities in Japanese Hospitals: A Principal Component Analysis-Based Cluster Analysis.Antibiotics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The threat from antimicrobial resistance (AMR) continues to grow. Japan's National Action Plan on Antimicrobial Resistance, which was formulated in 2016 and targets six areas, has already had a major impact on the countermeasures implemented against AMR. Particular advances have been made in AMR-related surveillance, and we now know the situation regarding antimicrobial use and antimicrobial-resistant bacteria in the country. Educational and awareness-raising activities for medical professionals and the general public have been actively implemented and seem to have contributed to a gradual move toward an appropriate use of antimicrobials. However, there is still insufficient understanding of the issue among the general public. Determining how to use surveillance results and implementing further awareness-raising activities are crucial to address this. Tasks for the future include both raising awareness and the promotion of AMR research and development and international cooperation. The government's next Action Plan, which will detail future countermeasures against AMR based on the outcomes of and tasks identified in the current Action Plan, has been delayed due to the COVID-19 pandemic and is urgently awaited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.